SlideShare a Scribd company logo
1 of 21
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Amarex Clinical Research Washington DC metro area
[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Acceptance of  Foreign Clinical Trial Data in  INDs and NDA/BLA  Mukesh Kumar, PhD, RAC Senior Director, Regulatory Affairs Amarex Clinical Research Germantown, MD  20874, USA Tel:  001-240-750-4893 Email:  [email_address]
Agenda for this Seminar ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Kinds of Foreign Clinical Trails ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IND Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-IND Studies ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Acceptance of  Foreign Clinical Data ,[object Object],[object Object],[object Object],[object Object],[object Object],21 CFR  §312.120 21 CFR  § 860.7
Global Clinical Trials Source: Clinicaltrials.gov
Most of FDA-Registered Investigators Are From the Developed Countries Source: Parexel's Bio/Pharmaceutical  R&D Statistical Sourcebook 2006/2007  Total No. of Investigators (~23000) Non-US Investigators 9.6% 3.9% 1.3% 1.5% 1.9%
FDA Guidance Documents ,[object Object],[object Object],[object Object]
ICH E5: Ethnic Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ICH E5: Main Elements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-IND Clinical Studies ,[object Object],[object Object],[object Object],[object Object]
Acceptance Criteria for non-IND studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acceptance Criteria for non-IND studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Practical Issues with using non-US sites in clinical trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Practical Issues with using non-US sites in clinical trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Best Options ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
Thank You! Questions and Comments  Mukesh Kumar, PhD, RAC Senior Director, Regulatory Affairs Amarex Clinical Research Germantown, MD  20874, USA Tel:  001-240-750-4893 Email:  [email_address]

More Related Content

What's hot

REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxAartiVats5
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1Jorge Torres
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTSPallavi Christeen
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Aakashdeep Raval
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESVikas Rathee
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50Rohit K.
 
Premarket Notification The 510(k) Process
Premarket Notification The 510(k) ProcessPremarket Notification The 510(k) Process
Premarket Notification The 510(k) ProcessMichael Swit
 
GMDNS, UDI, barcodes and more...
GMDNS, UDI, barcodes and more...GMDNS, UDI, barcodes and more...
GMDNS, UDI, barcodes and more...Paul Blackett
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Nirma University
 
Acceptance of foreign clinical trials.pptx
Acceptance of foreign clinical trials.pptxAcceptance of foreign clinical trials.pptx
Acceptance of foreign clinical trials.pptxdipakkendre2
 
Organizaton chart of us fda.
Organizaton chart of us fda.Organizaton chart of us fda.
Organizaton chart of us fda.Rovil Goel
 
Biologics and herbals.pptx
Biologics and herbals.pptxBiologics and herbals.pptx
Biologics and herbals.pptxZeelshah2258
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usVinod Raj
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical DevicesJacobe2008
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...Swapnil Fernandes
 

What's hot (20)

REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptx
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
 
Doc in pharma
Doc in pharmaDoc in pharma
Doc in pharma
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50
 
Premarket Notification The 510(k) Process
Premarket Notification The 510(k) ProcessPremarket Notification The 510(k) Process
Premarket Notification The 510(k) Process
 
China: Medical Device Regulations
China: Medical Device RegulationsChina: Medical Device Regulations
China: Medical Device Regulations
 
GMDNS, UDI, barcodes and more...
GMDNS, UDI, barcodes and more...GMDNS, UDI, barcodes and more...
GMDNS, UDI, barcodes and more...
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)
 
Acceptance of foreign clinical trials.pptx
Acceptance of foreign clinical trials.pptxAcceptance of foreign clinical trials.pptx
Acceptance of foreign clinical trials.pptx
 
Organizaton chart of us fda.
Organizaton chart of us fda.Organizaton chart of us fda.
Organizaton chart of us fda.
 
Biologics and herbals.pptx
Biologics and herbals.pptxBiologics and herbals.pptx
Biologics and herbals.pptx
 
Nsf standard
Nsf standardNsf standard
Nsf standard
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in us
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
 
GHTF
GHTFGHTF
GHTF
 
ICH E11.pptx
ICH E11.pptxICH E11.pptx
ICH E11.pptx
 

Viewers also liked

GDA 2015 presentation: Data and programming as part of your journalistic core...
GDA 2015 presentation: Data and programming as part of your journalistic core...GDA 2015 presentation: Data and programming as part of your journalistic core...
GDA 2015 presentation: Data and programming as part of your journalistic core...Greg Linch
 
EEC '12 - RiderState presentation - 2012
EEC '12 - RiderState presentation - 2012EEC '12 - RiderState presentation - 2012
EEC '12 - RiderState presentation - 2012Santi Casado
 
Presentation js lee
Presentation js leePresentation js lee
Presentation js leeIrene Tan
 
Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.
Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.
Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.king_cfc
 
Evolutie Si Creatie
Evolutie Si CreatieEvolutie Si Creatie
Evolutie Si Creatiealexcurbet
 
JISC BCE Programme Overview
JISC BCE Programme OverviewJISC BCE Programme Overview
JISC BCE Programme OverviewJISC BCE
 
What Can Records Management Do For You?
What Can Records Management Do For You?What Can Records Management Do For You?
What Can Records Management Do For You?JISC BCE
 
전통매체 위기의 구조와 미래 전망
전통매체 위기의 구조와 미래 전망전통매체 위기의 구조와 미래 전망
전통매체 위기의 구조와 미래 전망soon choi
 
Presentació Jesus
Presentació JesusPresentació Jesus
Presentació JesusNuria P
 
Processing workshop intro
Processing workshop introProcessing workshop intro
Processing workshop introJuraj Bednar
 
Team Hr Teaser
Team Hr TeaserTeam Hr Teaser
Team Hr Teaserlisa42
 

Viewers also liked (20)

4 types
4 types4 types
4 types
 
GDA 2015 presentation: Data and programming as part of your journalistic core...
GDA 2015 presentation: Data and programming as part of your journalistic core...GDA 2015 presentation: Data and programming as part of your journalistic core...
GDA 2015 presentation: Data and programming as part of your journalistic core...
 
Bobby97
Bobby97Bobby97
Bobby97
 
EEC '12 - RiderState presentation - 2012
EEC '12 - RiderState presentation - 2012EEC '12 - RiderState presentation - 2012
EEC '12 - RiderState presentation - 2012
 
Peer Awards Full
Peer Awards FullPeer Awards Full
Peer Awards Full
 
De Pe Flash
De Pe FlashDe Pe Flash
De Pe Flash
 
Presentation js lee
Presentation js leePresentation js lee
Presentation js lee
 
Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.
Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.
Truyen O Ky Tuc Xa Dai Hoc Thuong Mai Hanoi1.
 
Sailing
SailingSailing
Sailing
 
Paradise Bay Grand
Paradise Bay GrandParadise Bay Grand
Paradise Bay Grand
 
Evolutie Si Creatie
Evolutie Si CreatieEvolutie Si Creatie
Evolutie Si Creatie
 
Prepaid Legal
Prepaid LegalPrepaid Legal
Prepaid Legal
 
JISC BCE Programme Overview
JISC BCE Programme OverviewJISC BCE Programme Overview
JISC BCE Programme Overview
 
What Can Records Management Do For You?
What Can Records Management Do For You?What Can Records Management Do For You?
What Can Records Management Do For You?
 
전통매체 위기의 구조와 미래 전망
전통매체 위기의 구조와 미래 전망전통매체 위기의 구조와 미래 전망
전통매체 위기의 구조와 미래 전망
 
Presentació Jesus
Presentació JesusPresentació Jesus
Presentació Jesus
 
So_this_is_Xmas
So_this_is_XmasSo_this_is_Xmas
So_this_is_Xmas
 
Processing workshop intro
Processing workshop introProcessing workshop intro
Processing workshop intro
 
Team Hr Teaser
Team Hr TeaserTeam Hr Teaser
Team Hr Teaser
 
Examen Facil
Examen FacilExamen Facil
Examen Facil
 

Similar to Fda Acceptance Of Foreign Clinical Trial Data Feb 2009

Webinar: Clinical Trial Registration Jan 2009
Webinar: Clinical Trial Registration Jan 2009Webinar: Clinical Trial Registration Jan 2009
Webinar: Clinical Trial Registration Jan 2009Mukesh Kumar, PhD, RAC
 
Kassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptx
Kassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptxKassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptx
Kassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptxSapnaAkhani
 
Regulatory Challenges to Successful Global Clinical Studies
Regulatory Challenges to Successful Global Clinical StudiesRegulatory Challenges to Successful Global Clinical Studies
Regulatory Challenges to Successful Global Clinical StudiesMichael Swit
 
slideshow_may25story
slideshow_may25storyslideshow_may25story
slideshow_may25storymedcitymedia
 
ClinicalTrials.gov An Introduction Presented by Taw.docx
ClinicalTrials.gov  An Introduction Presented by Taw.docxClinicalTrials.gov  An Introduction Presented by Taw.docx
ClinicalTrials.gov An Introduction Presented by Taw.docxmccormicknadine86
 
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...MedicReS
 
NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...
NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...
NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...CGC, LANDRAN
 
The State of Clinical Development - Globalization
The State of Clinical Development - GlobalizationThe State of Clinical Development - Globalization
The State of Clinical Development - GlobalizationTTC, llc
 
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsDigital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsSC CTSI at USC and CHLA
 
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.govAllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.govSenseAboutSci
 
Designing of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameedDesigning of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameedRumana Hameed
 
Technical Due Diligence
Technical Due DiligenceTechnical Due Diligence
Technical Due Diligenceargentieri
 
Gcp 112070804017
Gcp 112070804017Gcp 112070804017
Gcp 112070804017Patel Parth
 
GCP Key Concepts NCI 4-19-17.pdf main concepts
GCP Key Concepts NCI 4-19-17.pdf main conceptsGCP Key Concepts NCI 4-19-17.pdf main concepts
GCP Key Concepts NCI 4-19-17.pdf main conceptsAakanksha38925
 
Real-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IReal-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IProlifiq Software
 
Compliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialCompliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialGood Promotional Practices
 
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...SC CTSI at USC and CHLA
 

Similar to Fda Acceptance Of Foreign Clinical Trial Data Feb 2009 (20)

Webinar: Clinical Trial Registration Jan 2009
Webinar: Clinical Trial Registration Jan 2009Webinar: Clinical Trial Registration Jan 2009
Webinar: Clinical Trial Registration Jan 2009
 
Kassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptx
Kassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptxKassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptx
Kassa Ayalew FDA Perspective on FCTs 2016_0 (1).pptx
 
Regulatory Challenges to Successful Global Clinical Studies
Regulatory Challenges to Successful Global Clinical StudiesRegulatory Challenges to Successful Global Clinical Studies
Regulatory Challenges to Successful Global Clinical Studies
 
slideshow_may25story
slideshow_may25storyslideshow_may25story
slideshow_may25story
 
Quality and Regulatory Affairs
Quality and Regulatory AffairsQuality and Regulatory Affairs
Quality and Regulatory Affairs
 
ClinicalTrials.gov An Introduction Presented by Taw.docx
ClinicalTrials.gov  An Introduction Presented by Taw.docxClinicalTrials.gov  An Introduction Presented by Taw.docx
ClinicalTrials.gov An Introduction Presented by Taw.docx
 
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
FDA 2013 Clinical Investigator Training Course: FDA Perspective on Internatio...
 
Gcp
GcpGcp
Gcp
 
NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...
NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...
NISHA YADAV ROLLNO. 2116102 PRESENTATION ON DEVELOPING CLINICAL TRIAL PROTOCO...
 
The State of Clinical Development - Globalization
The State of Clinical Development - GlobalizationThe State of Clinical Development - Globalization
The State of Clinical Development - Globalization
 
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsDigital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting Documents
 
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.govAllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
 
Designing of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameedDesigning of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameed
 
Technical Due Diligence
Technical Due DiligenceTechnical Due Diligence
Technical Due Diligence
 
Gcp 112070804017
Gcp 112070804017Gcp 112070804017
Gcp 112070804017
 
Elite research network 2011
Elite research network   2011Elite research network   2011
Elite research network 2011
 
GCP Key Concepts NCI 4-19-17.pdf main concepts
GCP Key Concepts NCI 4-19-17.pdf main conceptsGCP Key Concepts NCI 4-19-17.pdf main concepts
GCP Key Concepts NCI 4-19-17.pdf main concepts
 
Real-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IReal-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part I
 
Compliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialCompliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational Material
 
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
Digital Scholar Webinar: Breaking Down (Brick) Walls: Switching to Remote, Vi...
 

Recently uploaded

2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis UsageNeil Kimberley
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyotictsugar
 
Case study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detailCase study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detailAriel592675
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfpollardmorgan
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckHajeJanKamps
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory:  summary 2024IoT Insurance Observatory:  summary 2024
IoT Insurance Observatory: summary 2024Matteo Carbone
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfRbc Rbcua
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Servicecallgirls2057
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCRashishs7044
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...ictsugar
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 

Recently uploaded (20)

2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyot
 
Case study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detailCase study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detail
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
 
Call Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North GoaCall Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North Goa
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory:  summary 2024IoT Insurance Observatory:  summary 2024
IoT Insurance Observatory: summary 2024
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdf
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
 
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 

Fda Acceptance Of Foreign Clinical Trial Data Feb 2009

  • 1.
  • 2.
  • 3. FDA Acceptance of Foreign Clinical Trial Data in INDs and NDA/BLA Mukesh Kumar, PhD, RAC Senior Director, Regulatory Affairs Amarex Clinical Research Germantown, MD 20874, USA Tel: 001-240-750-4893 Email: [email_address]
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Global Clinical Trials Source: Clinicaltrials.gov
  • 10. Most of FDA-Registered Investigators Are From the Developed Countries Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2006/2007 Total No. of Investigators (~23000) Non-US Investigators 9.6% 3.9% 1.3% 1.5% 1.9%
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Thank You! Questions and Comments Mukesh Kumar, PhD, RAC Senior Director, Regulatory Affairs Amarex Clinical Research Germantown, MD 20874, USA Tel: 001-240-750-4893 Email: [email_address]